ST SC Pharmaceuticals: Passed the drug GMP compliance inspection

*ST SC Pharmaceuticals announced that the company recently received the "Drug GMP Compliance Inspection Notification" approved by the Hainan Provincial Drug Administration. The inspection scope includes lyophilized powder injections, active pharmaceutical ingredients, and related production lines. The inspection date is from June 11 to June 13, 2025, and the inspection conclusion meets the requirements of the Good Manufacturing Practice for drug production. This successful inspection indicates that the company's production quality management system complies with the requirements of the Good Manufacturing Practice for drug production, which is beneficial for maintaining stable production capacity and meeting market demand